Catherine Saez

Catherine Saez

  • Articles: 1423
  • Comments: 1

WTO TRIPS Council Looks At IP And The Public Interest, Importance Of Research Exemption

A relatively new topic of discussion at the World Trade Organization committee on intellectual property is the relationship between intellectual property and the public interest. This week, WTO delegates discussed the application and benefits of a regulatory exception to IP rights allowing earlier entry of generics to the market, known as the Bolar exception. The committee also heard about a request from least-developed countries (LDCs) to improve technology transfer measures that developed countries have the obligation to provide under WTO rules.

WTO TRIPS Council: For Some, IP-Intensive Industries Are Engine Of Economy. For Others, IP Alone Is Not Sufficient

The World Trade Organization committee on intellectual property met this week and gave an opportunity to WTO members to discuss the value of intellectual property for micro, small and medium sized enterprises (MSMEs), and its importance for IP-intensive industries. Several members, such as the European Union on behalf of its members presented data to illustrate the importance of IP for MSMEs. Meanwhile, India and South Africa remarked that IP is only one factor to promote innovation, but are not a sufficient ingredient.

WTO, WHO, WIPO Heads Share Views On Innovation And Access At Trilateral Symposium

How to encourage health innovations and make sure that new medicines, vaccines, or diagnostics will reach every person who needs them? That is a question which has been hotly debated in different fora. Yesterday, the World Trade Organization, UN World Health Organization, and UN World Intellectual Property Organization jointly held a symposium on how innovative technologies can promote the United Nations Sustainable Development Goals. The WHO director general called on his colleagues to support policies facilitating access to health technologies.

Swiss Panel Looks At Value-Based Drug Pricing, Link Between R&D And Prices

Some products are too cheap, generic drug companies do not invest in them because they do not make enough money out of them. Others seem astronomically expensive, and are said to include the costs of all research, successes and failures alike. Panellists at a recent Swiss-organised expert event in Bern concurred that something must done about pricing, and explored some surprising ways to do it.

Least Developed Countries Ask For Better Implementation Of TRIPS Tech Transfer Requirements

The World Trade Organization council on intellectual property rights will hold the first of its three annual meetings next week. The now-usual item on IP and innovation is joined by a discussion topic on IP and the public interest. Separately, the WTO least developed countries group has put forward a request that developed countries fully implement their technology transfer requirements under the WTO rules. The council meeting will be preceded by a high-level trilateral meeting of the WTO, World Health Organization and World Intellectual Property Organization.

Rising Patent Applications – And Challenges – For New Technologies, Artificial Intelligence

The steady increase in innovations relating to new digital technologies, in particular technologies using artificial intelligence, is matched by an upward patenting trend. The European Patent Office recently issued a study on the subject and is preparing a conference in May, while the World Intellectual Property Organization is working on its own in-depth study. However, the current patent system might not be ready for artificial intelligence-related inventions, according to a global standards-setting body.

Patenting Artificial Intelligence Might Hamper Progress, EFF Says

The Electronic Frontier Foundation launched a project last year to measure progress in artificial intelligence innovations and understand the legal, political, and technical issues potentially raised by those inventions. Some eight months later, the project has tracked rapid progress of those technologies, in particular in machine learning. According to the foundation, patents might be hampering the progress of artificial intelligence, and with the risk of patent trolls claiming rights on patents on machine learning systems.

New Chair’s Text On WIPO Broadcasting Treaty Reflects Country Proposals

The chair of the World Intellectual Property Organization committee on copyright issued revised language last week on core articles of a potential treaty protecting broadcasting organisations against signal piracy. The document shows a trimmer set of different proposals by countries during informal discussions to address issues such as what the treaty should protect, which rights should be granted, and who should benefit from such rights.

Do We Need A Global Body To Set Priorities For Diseases And Research?

A recent panel of health experts gathered at the hallowed Swiss Intellectual Property Institute in Bern (which counts Albert Einstein among its alumni) tackled some of the toughest questions facing global health policymakers with an eye toward actually solving them and not just restating polarised positions. One of the ideas discussed at the event was how priorities for diseases and research are handled at the global level.

On IPR, Major US Trading Partners In Firing Line Of US Industry, While Cancer Patients Ask For Access

Every year at this time, the Office of the United States Trade Representative collects comments from stakeholders for its review of how well US trading partners are behaving when it comes to protecting and enforcing the intellectual property rights of US companies. Pharmaceutical companies and an alliance of rights holding industries came prepared with a list of countries to be put on special watch lists, including Canada, Brazil, India, Malaysia, and Switzerland. A patient group, on the other hand, asked that trade interests not supersede access to medicines worldwide.

Leadership And Change: An Interview With Medicines Patent Pool Board Chair Marie-Paule Kieny

The unexpected announcement in December of the resignation of the Medicines Patent Pool executive director left the Pool searching for its new head. Marie-Paule Kieny, former World Health Organization assistant director general, now chair of the MPP governance board stepped in to oversee the MPP while the search goes on. She sat down recently for an interview with Intellectual Property Watch to explain that MPP is conducting business as usual, and is keeping firm in its plan to release the results of a feasibility study analysing the possibility for MPP to extend its licensing activities to other essential medicines still under patent.